S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Encompass Health Stock Forecast, Price & News

-1.68 (-2.67%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
468,855 shs
Average Volume
642,383 shs
Market Capitalization
$6.09 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

Encompass Health logo

About Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.


See More Headlines

Industry, Sector and Symbol

Health Care Facilities
Year Founded

Sales & Book Value

Annual Sales
$4.64 billion
Cash Flow
$5.27 per share
Book Value
$22.73 per share


Net Income
$284.20 million
Pretax Margin




Free Float
Market Cap
$6.09 billion

Company Calendar

Dividend Payable
Last Earnings
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

3.37 out of 5 stars

Medical Sector

3rd out of 1,392 stocks

Hospitals Industry

1st out of 8 stocks

Analyst Opinion: 4.6Community Rank: 5.0Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Encompass Health (NYSE:EHC) Frequently Asked Questions

Is Encompass Health a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health
or view top-rated stocks.

How has Encompass Health's stock price been impacted by COVID-19?

Encompass Health's stock was trading at $63.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EHC shares have decreased by 4.2% and is now trading at $61.18.
View which stocks have been most impacted by COVID-19

Are investors shorting Encompass Health?

Encompass Health saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 2,160,000 shares, an increase of 18.0% from the September 30th total of 1,830,000 shares. Based on an average trading volume of 599,400 shares, the days-to-cover ratio is currently 3.6 days. Currently, 2.2% of the company's shares are sold short.
View Encompass Health's Short Interest

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, January 25th 2022.
View our earnings forecast for Encompass Health

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) released its quarterly earnings results on Wednesday, October, 27th. The company reported $1.03 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.06 by $0.03. The business earned $1.28 billion during the quarter, compared to analysts' expectations of $1.31 billion. Encompass Health had a net margin of 8.10% and a trailing twelve-month return on equity of 19.87%. Encompass Health's revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.78 earnings per share.
View Encompass Health's earnings history

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Thursday, October 21st. Investors of record on Monday, January 3rd will be paid a dividend of $0.28 per share on Tuesday, January 18th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.83%. The ex-dividend date is Friday, December 31st.
View Encompass Health's dividend history

Is Encompass Health a good dividend stock?

Encompass Health pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.78%. The dividend payout ratio of Encompass Health is 27.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY 2021 earnings guidance on Wednesday, November, 3rd. The company provided earnings per share guidance of $4.230-$4.380 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.450. The company issued revenue guidance of $5.08 billion-$5.13 billion, compared to the consensus revenue estimate of $5.18 billion.

What price target have analysts set for EHC?

9 brokerages have issued 1 year price objectives for Encompass Health's shares. Their forecasts range from $75.00 to $104.00. On average, they expect Encompass Health's share price to reach $90.67 in the next year. This suggests a possible upside of 48.2% from the stock's current price.
View analysts' price targets for Encompass Health
or view top-rated stocks among Wall Street analysts.

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mark J. Tarr, President, Chief Executive Officer & Director
  • Douglas E. Coltharp, Chief Financial Officer & Executive Vice President
  • Elissa Joy Charbonneau, Chief Medical Officer
  • John Patrick Darby, Secretary, Executive VP & General Counsel
  • Andrew L. Price, Chief Accounting Officer & Senior Vice President

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include salesforce.com (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.55%), Wellington Management Group LLP (8.22%), William Blair Investment Management LLC (3.11%), Victory Capital Management Inc. (1.70%), Bank of New York Mellon Corp (1.50%) and TimesSquare Capital Management LLC (1.42%). Company insiders that own Encompass Health stock include Andrew L Price, Andrew L Price, Donald L Correll, Donald L Correll, Elissa Joy Charbonneau, Elissa Joy Charbonneau, Mark J Tarr and Mark J Tarr.
View institutional ownership trends for Encompass Health

Which institutional investors are selling Encompass Health stock?

EHC stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., American Century Companies Inc., William Blair Investment Management LLC, Millennium Management LLC, Neuberger Berman Group LLC, BlackRock Inc., Bank of Nova Scotia, and Schroder Investment Management Group.
View insider buying and selling activity for Encompass Health
or view top insider-selling stocks.

Which institutional investors are buying Encompass Health stock?

EHC stock was acquired by a variety of institutional investors in the last quarter, including Canyon Capital Advisors LLC, DekaBank Deutsche Girozentrale, Wellington Management Group LLP, Glenview Capital Management LLC, Polar Asset Management Partners Inc., Massachusetts Financial Services Co. MA, Deutsche Bank AG, and Morgan Stanley.
View insider buying and selling activity for Encompass Health
or or view top insider-buying stocks.

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $61.18.

How much money does Encompass Health make?

Encompass Health has a market capitalization of $6.09 billion and generates $4.64 billion in revenue each year. The company earns $284.20 million in net income (profit) each year or $4.06 on an earnings per share basis.

How many employees does Encompass Health have?

Encompass Health employs 43,000 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

Where are Encompass Health's headquarters?

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at (205) 967-7116, via email at [email protected], or via fax at 205-969-4719.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.